Structures by: Mohan P. S.
Total: 15
C32H25FN4O5
C32H25FN4O5
MedChemComm (2019) 10, 3 439-449
a=7.7342(5)Å b=11.9996(8)Å c=14.6465(10)Å
α=97.469(2)° β=92.265(2)° γ=91.035(2)°
C33H25N3O3,CH4O
C33H25N3O3,CH4O
New J. Chem. (2016) 40, 6 5164
a=12.1184(7)Å b=17.2908(11)Å c=13.0821(9)Å
α=90° β=100.846(4)° γ=90°
C30H26N4O4
C30H26N4O4
New J. Chem. (2016) 40, 6 5164
a=12.0551(3)Å b=18.3685(4)Å c=12.3323(3)Å
α=90° β=90.8980(10)° γ=90°
C31H25N3O4
C31H25N3O4
New J. Chem. (2016) 40, 6 5164
a=9.94810(10)Å b=10.86510(10)Å c=13.2427(2)Å
α=70.6430(10)° β=68.0390(10)° γ=87.7640(10)°
3-Bromomethyl-2-chloro-6-(dibromomethyl)quinoline
C11H7Br3ClN
Acta Crystallographica Section E (2015) 71, 5 o354-o355
a=8.9042(5)Å b=9.3375(4)Å c=15.5107(7)Å
α=90° β=104.553(5)° γ=90°
4'-(2-Methoxyquinolin-3-yl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',3''-indoline]-1,3,2''-trione
C30H23N3O4
Acta Crystallographica Section E (2015) 71, 12 o1038-o1039
a=10.9058(3)Å b=9.5178(5)Å c=23.8651(6)Å
α=90.00° β=95.378(2)° γ=90.00°
2-Methoxyquinoline-3-carbaldehyde
C11H9NO2
Acta Crystallographica Section E (2010) 66, 10 o2510
a=8.8206(6)Å b=4.8446(3)Å c=21.6828(14)Å
α=90.00° β=90.612(4)° γ=90.00°
2-{2-[3-(1<i>H</i>-Benzimidazol-2-yl)quinolin-2-yloxy]ethoxy}ethanol
C20H19N3O3
Acta Crystallographica Section E (2009) 65, 2 o401
a=11.9478(2)Å b=13.13380(10)Å c=12.4031(2)Å
α=90.00° β=118.7440(10)° γ=90.00°
3-(1<i>H</i>-Benzimidazol-2-yl)-2-chloro-8-methylquinoline
C17H12ClN3
Acta Crystallographica Section E (2009) 65, 2 o400
a=16.4721(15)Å b=9.0061(8)Å c=9.6643(9)Å
α=90.00° β=98.433(2)° γ=90.00°
4-Hydroxy-3-(1'-methyl-2-oxo-4'-phenylspiro[indoline-3,2'-pyrrolidine]-3-ylcarbonyl)quinolin-2(1<i>H</i>)-one
C28H23N3O4
Acta Crystallographica Section E (2010) 66, 4 o952
a=9.6918(3)Å b=11.0258(3)Å c=12.9663(4)Å
α=69.1110(10)° β=72.044(2)° γ=66.4100(10)°
8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-<i>a</i>]carbazole
C19H19NO2
Acta Crystallographica Section E (2010) 66, 7 o1581
a=8.290(5)Å b=8.693(5)Å c=21.326(5)Å
α=90.000(5)° β=90.742(5)° γ=90.000(5)°
(2<i>E</i>)-2-Benzylidene-9-phenyl-3,4-dihydroacridin-1(2<i>H</i>)-one
C26H19NO
Acta Crystallographica Section E (2014) 70, 8 o870
a=9.2222(3)Å b=10.7555(4)Å c=19.4962(5)Å
α=90.00° β=95.503(2)° γ=90.00°
(1<i>R</i>*,3'<i>S</i>*,4'<i>R</i>*)-4'-(4-Chlorophenyl)-3'-[(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)carbonyl]-1'-methylspiro[acenaphthylene-1,2'-pyrrolidin]-2-one
C32H23ClN2O4
Acta Crystallographica Section E (2011) 67, 12 o3376-o3377
a=10.7447(7)Å b=14.1678(9)Å c=18.3858(11)Å
α=101.328(3)° β=91.945(3)° γ=105.388(3)°
C16H13N5O2S
C16H13N5O2S
ACS omega (2020) 5, 42 27245-27253
a=13.888(2)Å b=4.7349(8)Å c=23.274(4)Å
α=90° β=91.509(6)° γ=90°
C18H15N5O2S
C18H15N5O2S
ACS omega (2020) 5, 42 27245-27253
a=12.8882(12)Å b=16.8832(15)Å c=7.8668(7)Å
α=90° β=106.261(3)° γ=90°